Company profile: Emisphere Technologies
1.1 - Company Overview
Company description
- Provider of proprietary Eligen Technology to develop new oral formulations of therapeutic agents, enhancing absorption of drugs typically administered via injection. A pharmaceutical company with multiple product candidates in clinical development and several in pre-clinical research.
Products and services
- Eligen Technology: Proprietary platform employed to engineer oral formulations of therapeutic agents, enhancing absorption of drugs typically administered via injection for improved oral bioavailability
- Clinical Development Pipeline: Clinical-stage programs advancing multiple product candidates that create new oral formulations using Eligen Technology, converting injectable therapeutics into orally administered agents by enhancing absorption
- Pre-clinical Development and Research: Pre-clinical initiatives exploring additional product candidates to architect oral formulations of therapeutic agents, leveraging Eligen Technology’s absorption enhancement for drugs commonly given by injection
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Emisphere Technologies
scPharmaceuticals
HQ: United States
Website
- Description: Provider of biopharmaceutical products for subcutaneous delivery, including FUROSCIX, a furosemide injection for subcutaneous use to treat congestion due to fluid overload in adult patients with heart failure, and an investigational subcutaneous ceftriaxone delivery system for outpatient antibiotic therapy. Offers clinical trials, supports investigator-sponsored studies, educational grants, and medical information services.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full scPharmaceuticals company profile →
EryDel
HQ: Italy
Website
- Description: Provider of red blood cell-based drug delivery technologies and therapies. Offers the AIDE platform for autologous intracellular drug encapsulation, the CE marked Red Cell Loader device and EryKit for point-of-care loading, and EryDex, a patient-specific dexamethasone sodium phosphate treatment for Ataxia-Telangiectasia; conducting the NEAT Phase 3 trial evaluating EryDex's neurological effects.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full EryDel company profile →
Suono Bio
HQ: United States
Website
- Description: Provider of ultrasound-mediated drug delivery platforms enabling ultra-rapid delivery of small molecules, biologics, and nucleic acids to the gastrointestinal tract and directly into cells without encapsulation; offerings include Ultrasonic Enhanced Delivery and SuonoCalm for treating inflammatory conditions.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Suono Bio company profile →
Nutriband
HQ: United States
Website
- Description: Provider of abuse-deterrent transdermal technologies and drug delivery systems, including the AVERSA platform integrating abuse-deterrent features into patches for fentanyl, buprenorphine, and methylphenidate, and 4P transdermal systems delivering Exenatide for Type 2 Diabetes and FSH for infertility.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Nutriband company profile →
Medical International Technology
HQ: Canada
Website
- Description: Provider of needle-free jet injectors for human and animal vaccinations, developing, marketing, and distributing these devices.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Medical International Technology company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Emisphere Technologies
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Emisphere Technologies
2.2 - Growth funds investing in similar companies to Emisphere Technologies
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Emisphere Technologies
4.2 - Public trading comparable groups for Emisphere Technologies
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →